Skip to main content

Indices of oxidative stress in Parkinson’s disease, Alzheimer’s disease and dementia with Lewy bodies

  • Conference paper
Dementia in Parkinsonism

Part of the book series: Journal of Neural Transmission. Supplementa ((NEURAL SUPPL,volume 51))

Summary

The cause of neuronal cell death in Parkinson’s disease is unknown but there is accumulating evidence suggesting that oxidative stress may be involved in this process. Current evidence shows that in the substantia nigra there is altered iron metabolism, decreased levels of reduced glutathione and an impairment of mitochondrial complex I activity. However, these changes seem to be unique to the substantia nigra and have not been found in other areas of the brain known to be altered in Parkinson’s disease, such as substantia innominata. In addition they do not appear to be related to the presence of Lewy bodies, as other areas of the brain containing Lewy bodies do not show evidence of either oxidative stress or mitochondrial dysfunction. Oxidative stress has now been demonstrated in Alzheimer’s disease and its presence appears to be correlated with regions of marked pathological changes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (Canada)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (Canada)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (Canada)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  • Dexter DT, Wells FR, Agid F, Agid Y, Lees AJ, Jenner P, Marsden CD (1987) Increased nigral iron content in post-mortem parkinsonian brain. Lancet ii: 219–220.

    Google Scholar 

  • Dexter DT, Carter CJ, Wells FR, Javoy-Agid F, Agid Y, Lees A, Jenner P, Marsden CD (1989) Basal lipid peroxidation in substantia nigra is increased in Parkinson’s disease. J Neurochem 52: 381–389.

    Article  PubMed  CAS  Google Scholar 

  • Dexter DT, Wells FR, Lees AJ, Agid F, Agid Y, Jenner P, Marsden CD (1989) Increased nigral iron content and alterations in other metal ions occurring in the brain in Parkinson’s disease. J Neurochem 52: 1830–1836.

    Article  PubMed  CAS  Google Scholar 

  • Dexter DT, Carayon A, Vidaillhet M, Ruberg M, Agid F, Agid Y, Lees AJ, Wells FR, Jenner P, Marsden CD (1990) Decreased ferritin levels in brain in Parkinson’s disease. J Neurochem 55: 16–20.

    Article  PubMed  CAS  Google Scholar 

  • Dexter DT, Sian J, Jenner P, Marsden CD (1993) Implications of alterations in trace element levels in brain in Parkinson’s disease and other neurological disorders affecting the basal ganglia. Adv Neurol 60: 273–281.

    PubMed  CAS  Google Scholar 

  • Dexter DT, Sian J, Rose S, Hindmarsh JG, Mann VM, Cooper JM, Wells FR, Daniel S, Lees AJ, Schapira AHV, Jenner P, Marsden CD (1994) Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy Body disease. Ann Neurol 35: 38–44.

    Article  PubMed  CAS  Google Scholar 

  • Jenner P (1994) Oxidative damage in neurodegenerative disease. Lancet 344: 796–798.

    Article  PubMed  CAS  Google Scholar 

  • Mann VM, Cooper JM, Daniel SE, Srai K, Jenner P, Marsden CD, Schapira AHV (1994) Complex I, iron and ferritin in Parkinson’s disease substantia nigra. Ann Neurol 36: 876–881.

    Article  PubMed  CAS  Google Scholar 

  • Mastrogiacomo F, Bergeron C, Kish SJ (1993) Brain α-ketoglutarate dehydrogenase complex activity in Alzheimer’s disease. J Neurochem 61: 2007–2014.

    Article  PubMed  CAS  Google Scholar 

  • Mecocci P, MacGarvey U, Flint-Beal M (1994) Oxidative damage to mitochondrial DNA is increased in Alzheimer’s disease. Ann Neurol 36: 747–751.

    Article  PubMed  CAS  Google Scholar 

  • Mizuno Y, Matsuda S, Yoshina H, Mori H, Hattori N (1994) An immunohistochemical study of α-ketoglutarate dehydrogenase complex in Parkinson’s disease. Ann Neurol 35: 204–210.

    Article  PubMed  CAS  Google Scholar 

  • Palmer AM, Burns MA (1994) Selective increase in lipid peroxidation in the inferior temporal cortex in Alzheimer’s disease. Brain Res 645: 338–342.

    Article  PubMed  CAS  Google Scholar 

  • Parker WD, Parks JK (1995) Cytochrome c oxidase in Alzheimer’s disease brain: purification and characterization. Neurol 45: 482–486.

    Article  Google Scholar 

  • Perry T, Godin DV, Hansen S (1982) Parkinson’s disease: a disorder due to nigral glutathione deficiency. Neurosci Lett 33: 305–310.

    Article  PubMed  CAS  Google Scholar 

  • Perry E, McKeith I, Perry R (1996) Dementia with Lewy bodies: clinical, pathological and treatment issues. Cambridge University Press.

    Book  Google Scholar 

  • Reiderer P, Sofie E, Rausch W-D, Schmidt B, Reynolds GP, Jellinger K, Youdim MB (1989) Transition metals, ferritin, glutathione and ascorbic acid in Parkinson’s disease. J Neurochem 52: 381–389.

    Article  Google Scholar 

  • Sanchezramos JR, Overvik E, Ames BN (1994) A marker of oxyradical-mediated DNA damage (8-hydroxy-2′deoxyguanosine) is increased in nigro-striatum of Parkinson’s disease brain. Neurodegeneration 3: 197–204.

    Google Scholar 

  • Schapira AHV, Cooper JM, Dexter DT, Clark JB, Jenner P, Marsden CD (1990a) Mitochondrial complex I deficiency in Parkinson’s disease. J Neurochem 54: 823–827.

    Article  PubMed  CAS  Google Scholar 

  • Schapira AHV, Mann VM, Cooper JM, Dexter DT, Daniel SE, Jenner P, Clark JB, Marsden CD (1990b) Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson’s disease. J Neurochem 55: 2142–2145.

    Article  PubMed  CAS  Google Scholar 

  • Sian J, Dexter DT, Lees AJ, Daniel S, Agid Y, Javoy-Agid F, Jenner P, Marsden CD (1994) Alterations in glutathione levels in Parkinson’s disease and other neurodegenerative disorders affecting the basal ganglia. Ann Neurol 36: 348–355.

    Article  PubMed  CAS  Google Scholar 

  • Sian J, Dexter DT, Lees AJ, Daniel S, Jenner P, Marsden CD (1994) Glutathione-related enzymes in brain in Parkinson’s disease. Ann Neurol 36: 356–361.

    Article  PubMed  CAS  Google Scholar 

  • Sofic E, Reiderer P, Heinsen, Beckmann H, Reynolds GP, Hebenstreit G, Youdim MB (1988) Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain. J Neural Transm 74: 199–205.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer-Verlag/Wien

About this paper

Cite this paper

Owen, A.D., Schapira, A.H.V., Jenner, P., Marsden, C.D. (1997). Indices of oxidative stress in Parkinson’s disease, Alzheimer’s disease and dementia with Lewy bodies. In: Daniel, S.E., Cruz-Sánchez, F.F., Lees, A.J. (eds) Dementia in Parkinsonism. Journal of Neural Transmission. Supplementa, vol 51. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6846-2_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-6846-2_14

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-82959-2

  • Online ISBN: 978-3-7091-6846-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics